Works by Ibrahim, Nageatte


Results: 15
    1
    2
    3
    4
    5
    6
    7
    8

    Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.

    Published in:
    2013
    By:
    • Luke, Jason J;
    • Callahan, Margaret K;
    • Postow, Michael A;
    • Romano, Emanuela;
    • Ramaiya, Nikhil;
    • Bluth, Mark;
    • Giobbie-Hurder, Anita;
    • Lawrence, Donald P;
    • Ibrahim, Nageatte;
    • Ott, Patrick A;
    • Flaherty, Keith T;
    • Sullivan, Ryan J;
    • Harding, James J;
    • D'Angelo, Sandra;
    • Dickson, Mark;
    • Schwartz, Gary K;
    • Chapman, Paul B;
    • Wolchok, Jedd D;
    • Hodi, F Stephen;
    • Carvajal, Richard D
    Publication type:
    journal article
    9

    Clinical Activity of Ipilimumab for Metastatic Uveal Melanoma.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 20, p. 3687, doi. 10.1002/cncr.28282
    By:
    • Luke, Jason J.;
    • Callahan, Margaret K.;
    • Postow, Michael A.;
    • Romano, Emanuela;
    • Ramaiya, Nikhil;
    • Bluth, Mark;
    • Giobbie‐Hurder, Anita;
    • Lawrence, Donald P.;
    • Ibrahim, Nageatte;
    • Ott, Patrick A.;
    • Flaherty, Keith T.;
    • Sullivan, Ryan J.;
    • Harding, James J.;
    • D'Angelo, Sandra;
    • Dickson, Mark;
    • Schwartz, Gary K.;
    • Chapman, Paul B.;
    • Wolchok, Jedd D.;
    • Hodi, F. Stephen;
    • Carvajal, Richard D.
    Publication type:
    Article
    10

    Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.

    Published in:
    2020
    By:
    • Tolcher, Anthony W.;
    • Kurzrock, Razelle;
    • Valero, Vincente;
    • Gonzalez, Rene;
    • Heist, Rebecca S.;
    • Tan, Antoinette R.;
    • Means-Powell, Julie;
    • Werner, Theresa L.;
    • Becerra, Carlos;
    • Wang, Chenxi;
    • Leonowens, Cathrine;
    • Kalyana-Sundaram, Shanker;
    • Kleha, Joseph F.;
    • Gauvin, Jennifer;
    • D'Amelio, Anthony M.;
    • Ellis, Catherine;
    • Ibrahim, Nageatte;
    • Yan, Li;
    • D'Amelio, Anthony M Jr
    Publication type:
    journal article
    11
    12
    13

    A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant Melanoma.

    Published in:
    Oncologist, 2015, v. 20, n. 6, p. 617, doi. 10.1634/theoncologist.2015-0105
    By:
    • Sullivan, Ryan J.;
    • Ibrahim, Nageatte;
    • Lawrence, Donald P.;
    • Aldridge, Julie;
    • Giobbie‐Hurder, Anita;
    • Hodi, F. Stephen;
    • Flaherty, Keith T.;
    • Conley, Christine;
    • Mier, James W.;
    • Atkins, Michael B.;
    • McDermott, David F.
    Publication type:
    Article
    14

    Ipilimumab for Patients With Advanced Mucosal Melanoma.

    Published in:
    Oncologist, 2013, v. 18, n. 6, p. 726, doi. 10.1634/theoncologist.2012-0464
    By:
    • Postow, Michael A.;
    • Luke, Jason J.;
    • Bluth, Mark J.;
    • Ramaiya, Nikhil;
    • Panageas, Katherine S.;
    • Lawrence, Donald P.;
    • Ibrahim, Nageatte;
    • Flaherty, Keith T.;
    • Sullivan, Ryan J.;
    • Ott, Patrick A.;
    • Callahan, Margaret K.;
    • Harding, James J.;
    • D'Angelo, Sandra P.;
    • Dickson, Mark A.;
    • Schwartz, Gary K.;
    • Chapman, Paul B.;
    • Gnjatic, Sacha;
    • Wolchok, Jedd D.;
    • Hodi, F. Stephen;
    • Carvajal, Richard D.
    Publication type:
    Article
    15